Advanced Enzyme Technologies Limited ADVENZYMES NSEINFRA

Basic Materials · Specialty Chemicals · India

https://www.advancedenzymes.com

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications, biofuels, and bio-catalysis. It also provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is headquartered in Thane, India.

Market & Price

Market Cap

₹4,075.93 Cr

Current Price

₹364.00

High / Low (52W)

₹390.40 / ₹255.30

Beta

Valuation

Stock P/E

24.15

Industry PE

23.81

Forward P/E

19.78

PEG Ratio

Book Value

₹145.86

Price to Book

2.50

P/S

5.22

EV/EBITDA

13.10

Dividend Yield

1.43%

Profitability & Returns

ROCE

13.58%

ROE

11.02%

ROA

8.09%

Profit Margin

21.61%

Op Margin

28.62%

EPS (Latest Qtr)

₹3.84

EPS (TTM)

₹15.07

Balance Sheet & Liquidity

Debt/Equity

1.90

Quick Ratio

7.92

Current Ratio

9.78

Debt

₹32.01 Cr

Total Assets

₹1,838.76 Cr

Current Assets

₹1,043.57 Cr

Working Capital

₹936.85 Cr

Ownership

Promoter Holding

55.48%

Chg in Prom Hold

-0.04%

FII / Inst Holding

20.54%

Chg in FII Hold

-0.00%

Financial Snapshot

Enterprise Value

₹3,455.95 Cr

Total Revenue (TTM)

₹780.59 Cr

EBITDA

₹263.90 Cr

Free Cash Flow

₹77.79 Cr

Operating Cash Flow

₹156.78 Cr

Shares Outstanding

₹11.20 Cr

Gross Margin

75.28%

Payout Ratio

34.53%

Growth (CAGR)

Revenue 5Y

11.34%

Profit 5Y

16.89%

Revenue (YoY)

26.00%

Earnings (YoY)

62.00%

PROS

Excellent profit margin of 21.6%.
Compounding revenue at 11.3% over 5 years.
Profit CAGR of 16.9% over 5 years.
Generates positive free cash flow.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Price Chart

NSE TradingView Screener.in

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Basic Materials).

#	Name	CMP ₹	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	ADVENZYMES Advanced Enzyme Technologies Limited NSEINFRA	364.00	24.15	₹4,075.93 Cr	1.43%	13.58%	11.02%	11.34%	16.89%
2	ULTRACEMCO UltraTech Cement Limited NIFTY50NSEINFRA	11,482.00	41.32	₹3.38 L Cr	0.67%	11.90%	10.59%	12.40%	17.26%
3	JSWSTEEL JSW Steel Limited NIFTY50NSEAIINFRA	1,278.00	14.01	₹3.12 L Cr	0.56%	19.15%	27.26%	3.61%	75.28%
4	HINDZINC Hindustan Zinc Limited NSEINFRA	632.95	19.34	₹2.67 L Cr	3.32%	62.35%	76.94%	5.61%	9.58%
5	TATASTEEL Tata Steel Limited NIFTY50NSEAIINFRA	208.02	28.34	₹2.59 L Cr	1.92%	11.32%	11.16%	-1.59%	7.21%
6	HINDALCO Hindalco Industries Limited NIFTY50NSEAIINFRA	1,126.70	18.73	₹2.52 L Cr	0.44%	9.50%	10.29%	7.40%	9.87%
7	GRASIM Grasim Industries Limited NIFTY50NSEINFRA	3,122.40	42.74	₹2.12 L Cr	0.32%	4.00%	6.29%	14.63%	-10.06%
8	SOLARINDS Solar Industries India Limited NSEINFRA	18,247.00	98.04	₹1.65 L Cr	0.06%	29.51%	31.33%	13.27%	30.36%
9	PIDILITIND Pidilite Industries Limited NSEINFRA	1,482.80	61.73	₹1.51 L Cr	0.67%	28.48%	23.52%	7.50%	24.36%

Quarterly Results

Figures in INR.

Metric	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	167.18 Cr	185.91 Cr	184.53 Cr	171.95 Cr	203.37 Cr
Cost of Revenue	46.09 Cr	50.05 Cr	44.57 Cr	41.41 Cr	56.93 Cr
Gross Profit	121.09 Cr	135.87 Cr	139.96 Cr	130.54 Cr	146.44 Cr
Operating Expenses	85.57 Cr	89.05 Cr	89.98 Cr	91.40 Cr	93.40 Cr
Operating Income	35.53 Cr	46.81 Cr	49.98 Cr	39.14 Cr	53.04 Cr
EBITDA	54.35 Cr	65.28 Cr	70.34 Cr	69.06 Cr	70.57 Cr
Interest Expense	81.10 L	76.40 L	72.20 L	56.80 L	57.30 L
Pretax Income	43.46 Cr	54.90 Cr	59.54 Cr	58.29 Cr	59.80 Cr
Tax Provision	16.73 Cr	14.46 Cr	14.81 Cr	15.11 Cr	14.55 Cr
Net Income	26.48 Cr	39.93 Cr	43.33 Cr	42.50 Cr	42.96 Cr
Diluted EPS	2.37	3.57	3.87	3.79	3.84

Profit & Loss (Annual)

Figures in INR.

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Revenue	-	540.38 Cr	623.48 Cr	636.91 Cr	745.76 Cr
Cost of Revenue	-	142.77 Cr	159.41 Cr	151.86 Cr	192.95 Cr
Gross Profit	-	397.61 Cr	464.07 Cr	485.05 Cr	552.81 Cr
Operating Expenses	-	259.32 Cr	291.24 Cr	327.17 Cr	363.83 Cr
Operating Income	-	138.30 Cr	172.83 Cr	157.88 Cr	188.97 Cr
EBITDA	-	177.84 Cr	225.99 Cr	227.48 Cr	275.26 Cr
Interest Expense	-	2.42 Cr	2.93 Cr	3.56 Cr	2.63 Cr
Pretax Income	-	140.39 Cr	187.82 Cr	187.36 Cr	232.54 Cr
Tax Provision	-	36.52 Cr	50.87 Cr	53.39 Cr	58.93 Cr
Net Income	-	105.64 Cr	133.31 Cr	131.12 Cr	168.72 Cr
Diluted EPS	10.68	9.45	11.92	11.71	-

Compounded Sales Growth

5 Years:	11.34%
1 Year:	26.00%

Compounded Profit Growth

5 Years:	16.89%
1 Year:	62.00%

Stock Price Performance

1 Year:	+18.39%
6 Months:	+16.67%
3 Months:	+15.96%
1 Month:	+7.77%

Balance Sheet (Annual)

Figures in INR.

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Total Assets	-	1,421.85 Cr	1,535.46 Cr	1,621.35 Cr	1,838.76 Cr
Current Assets	-	721.06 Cr	809.47 Cr	879.87 Cr	1,043.57 Cr
Cash & Equivalents	-	96.42 Cr	113.75 Cr	94.22 Cr	108.75 Cr
Inventory	-	123.99 Cr	148.46 Cr	157.31 Cr	177.28 Cr
Receivables	-	100.34 Cr	98.57 Cr	115.40 Cr	145.02 Cr
Total Liabilities	-	137.68 Cr	164.38 Cr	152.68 Cr	155.64 Cr
Current Liabilities	-	77.57 Cr	106.36 Cr	96.75 Cr	106.72 Cr
Long Term Debt	-	7.80 Cr	6.96 Cr	9.18 Cr	7.89 Cr
Total Debt	-	33.50 Cr	47.31 Cr	39.35 Cr	32.01 Cr
Total Equity	-	1,235.07 Cr	1,324.13 Cr	1,420.86 Cr	1,631.96 Cr
Shares Outstanding	-	11.18 Cr	11.18 Cr	11.19 Cr	11.19 Cr

Cash Flows (Annual)

Figures in INR.

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow	-	140.36 Cr	141.37 Cr	142.50 Cr	156.78 Cr
Investing Cash Flow	-	-298.18 Cr	-64.65 Cr	-89.10 Cr	-74.13 Cr
Financing Cash Flow	-	-25.80 Cr	-59.24 Cr	-72.54 Cr	-70.37 Cr
Capital Expenditure	-	-38.18 Cr	-47.31 Cr	-34.78 Cr	-52.38 Cr
Free Cash Flow	-	102.18 Cr	94.06 Cr	107.72 Cr	104.40 Cr
Net Change in Cash	-	-183.62 Cr	17.48 Cr	-19.15 Cr	12.28 Cr

Ratios (Annual)

Figures in %.

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Gross Margin %	-	73.6%	74.4%	76.2%	74.1%
Operating Margin %	-	25.6%	27.7%	24.8%	25.3%
Net Margin %	-	19.5%	21.4%	20.6%	22.6%
ROE %	-	8.6%	10.1%	9.2%	10.3%
ROCE %	-	10.3%	12.1%	10.4%	10.9%

Shareholding Pattern

Insiders

55.48%

Institutions

20.54%

Public Float

46.13%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for ADVENZYMES

No recent headlines available.

ADVENZYMES · Basic Materials